QuickView for TAKL%3Bjsessionid%3D40E22499564EAE7F71FA29AA19705F76%3Bjsessionid%3D787005E39F3AFF5E382EC41A340AB170%3Bjsessionid%3D31FD067A41084A84C97BE51309D7990D%3Bjsessionid%3D239C40B3727C3880B4DD59FDA993EB74%3Bjsessionid%3D12274BD3F00DF96945107322433EFB2D%3Bjsessionid%3DBABECBC0925C4C2EF20C533A8061A2D4%3Bjsessionid%3DA9E1B4939F78E3E99513BEFDCAAEE7BF%3Bjsessionid%3D0D3DBCFC8B84ADDE75E42324D8084A8D%3Bjsessionid%3D3EFD0032CB15AA01F0040163408157F0%3Bjsessionid%3D7D16C35F2459D7EAE6FAF343D45E87E2%3Bjsessionid%3D3167845A0E3768D7575D02765CB82CA8%3Bjsessionid%3D8CF063BC1B746A0E7DD85BD20B755A4A%3Bjsessionid%3D2AF3BA0573DA18F14024CF6C062E9995%3Bjsessionid%3D43BF91C891D8300117245FFD6691A4C0%3Bjsessionid%3DDBD095BCCA38433041347AA587F55A81%3Bjsessionid%3DA1E308CF1FD395834B52B6503334BEEC%3Bjsessionid%3DF2FC8EFD593F9A16E66F616FE41E66CE%3Bjsessionid%3D058760CF5BFDB1B7EDF27911D4801CD5%3Bjsessionid%3DF0EBCCD9EFB30CCFC627E31CF47010FA%3Bjsessionid%3DC0386A51017EFCC090264BFE259ACA32%3Bjsessionid%3DEC0B3A52A9C010DB91C4C78E539F11B5%3Bjsessionid%3D6B17DF1AB307027FD37B31A86935B57E%3Bjsessionid%3D8AD51A19C3B9AE41F47E684C7C26EFE1 (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL%3Bjsessionid%3D40E22499564EAE7F71FA29AA19705F76%3Bjsessionid%3D787005E39F3AFF5E382EC41A340AB170%3Bjsessionid%3D31FD067A41084A84C97BE51309D7990D%3Bjsessionid%3D239C40B3727C3880B4DD59FDA993EB74%3Bjsessionid%3D12274BD3F00DF96945107322433EFB2D%3Bjsessionid%3DBABECBC0925C4C2EF20C533A8061A2D4%3Bjsessionid%3DA9E1B4939F78E3E99513BEFDCAAEE7BF%3Bjsessionid%3D0D3DBCFC8B84ADDE75E42324D8084A8D%3Bjsessionid%3D3EFD0032CB15AA01F0040163408157F0%3Bjsessionid%3D7D16C35F2459D7EAE6FAF343D45E87E2%3Bjsessionid%3D3167845A0E3768D7575D02765CB82CA8%3Bjsessionid%3D8CF063BC1B746A0E7DD85BD20B755A4A%3Bjsessionid%3D2AF3BA0573DA18F14024CF6C062E9995%3Bjsessionid%3D43BF91C891D8300117245FFD6691A4C0%3Bjsessionid%3DDBD095BCCA38433041347AA587F55A81%3Bjsessionid%3DA1E308CF1FD395834B52B6503334BEEC%3Bjsessionid%3DF2FC8EFD593F9A16E66F616FE41E66CE%3Bjsessionid%3D058760CF5BFDB1B7EDF27911D4801CD5%3Bjsessionid%3DF0EBCCD9EFB30CCFC627E31CF47010FA%3Bjsessionid%3DC0386A51017EFCC090264BFE259ACA32%3Bjsessionid%3DEC0B3A52A9C010DB91C4C78E539F11B5%3Bjsessionid%3D6B17DF1AB307027FD37B31A86935B57E%3Bjsessionid%3D8AD51A19C3B9AE41F47E684C7C26EFE1